Related Experiment Video
Updated: Aug 7, 2026

High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors
Published on: March 22, 2011
Heat-directed gene targeting of adenoviral vectors to tumor cells
1Department of Medical Biophysics, University of Toronto, Ontario, Canada.
Abstract:
Targeting therapeutic gene expression to tumor cells represents a major challenge for cancer gene therapy. The strong transcriptional response exhibited by heat shock genes, along with the beneficial therapeutic effects of hyperthermia have led us to develop a heat-directed gene-targeting strategy for cancer treatment. Heat shock gene expression is mediated in large part by the interaction of heat shock factor 1 with specific binding sites (heat shock elements; HSE) found in the promoters of heat-inducible genes. Here we present a quantitative analysis of heat-inducible gene expression mediated by the wild-type hsp70b gene promoter, as well as a modified hsp70b promoter containing additional HSE sequences. Beta-galactosidase (beta-gal) expression was induced between 50- and 800-fold in a panel of human breast cancer cell lines infected with an adenoviral vector containing the wild-type hsp70b promoter (Ad.70b.betag) following treatment at 43 degrees C for 30 minutes. Infection with an adenoviral vector containing the modified hsp70b promoter (Ad.HSE.70b.betag) resulted in a 200- to 950-fold increase in beta-gal expression under the same conditions, and also provided a 1-2 degrees C decrease in the threshold of activation. Significant increases in the heat responsiveness of the Ad.HSE.70b.betag construct were observed in five of six tumor cell lines tested, as well as under thermotolerant conditions. Finally, we demonstrate that localized heating of a HeLa cell xenograft can effectively target beta-gal gene expression following intratumoral injection of Ad.70b.betag. Adenoviral vectors incorporating heat-inducible therapeutic genes may provide useful adjuncts for clinical hyperthermia.
Insights
This study developed a heat-directed gene therapy for cancer using modified heat shock promoters. Enhanced heat responsiveness in tumor cells and xenografts shows promise for clinical hyperthermia.
Area of Science:
- Oncology
- Molecular Biology
- Gene Therapy
Background:
- Targeting gene expression to tumor cells is crucial for effective cancer gene therapy.
- Heat shock genes exhibit strong transcriptional responses, and hyperthermia offers therapeutic benefits.
- Heat shock factor 1 (HSF1) binding to heat shock elements (HSE) in promoters regulates heat-inducible genes.
Purpose of the Study:
- To develop and analyze a heat-directed gene-targeting strategy for cancer treatment.
- To quantitatively analyze heat-inducible gene expression using wild-type and modified hsp70b promoters.
- To assess the efficacy of heat-inducible gene expression in cancer cell lines and in vivo tumor models.
Main Methods:
- Quantitative analysis of beta-galactosidase (beta-gal) expression mediated by wild-type and modified hsp70b gene promoters.
- Utilized adenoviral vectors (Ad.70b.betag and Ad.HSE.70b.betag) for gene delivery in human breast cancer cell lines.
- Investigated gene expression under hyperthermic conditions (43°C for 30 minutes) and in a HeLa cell xenograft model.
Main Results:
- Infection with Ad.70b.betag resulted in 50- to 800-fold induction of beta-gal expression.
- Infection with Ad.HSE.70b.betag yielded a 200- to 950-fold increase in beta-gal expression, with a 1-2°C lower activation threshold.
- The modified promoter (Ad.HSE.70b.betag) showed enhanced heat responsiveness in five of six tumor cell lines and under thermotolerant conditions.
- Localized heating of a HeLa cell xenograft effectively targeted beta-gal gene expression after intratumoral injection of Ad.70b.betag.
Conclusions:
- Modified hsp70b promoters with additional HSE sequences enhance heat-inducible gene expression.
- This heat-directed gene-targeting strategy shows potential for improved cancer treatment.
- Adenoviral vectors with heat-inducible genes may serve as valuable adjuncts in clinical hyperthermia treatments.
More Related Videos
08:14Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting
Published on: October 26, 2018
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Related Concept Videos
In-vitro Mutagenesis
Gene Therapy